AU2003280544A1 - A special kind of indole compounds, their preparation, and their use in treatment and prevention of those disease such as cancer - Google Patents
A special kind of indole compounds, their preparation, and their use in treatment and prevention of those disease such as cancerInfo
- Publication number
- AU2003280544A1 AU2003280544A1 AU2003280544A AU2003280544A AU2003280544A1 AU 2003280544 A1 AU2003280544 A1 AU 2003280544A1 AU 2003280544 A AU2003280544 A AU 2003280544A AU 2003280544 A AU2003280544 A AU 2003280544A AU 2003280544 A1 AU2003280544 A1 AU 2003280544A1
- Authority
- AU
- Australia
- Prior art keywords
- cancer
- prevention
- preparation
- treatment
- indole compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021385181A CN1199946C (en) | 2002-10-29 | 2002-10-29 | Specific indole compound and its preparation and use in treating and preventing cancers |
CN02138518.1 | 2002-10-29 | ||
PCT/CN2003/000901 WO2004039797A1 (en) | 2002-10-29 | 2003-10-27 | A special kind of indole compounds, their preparation, and their use in treatment and prevention of those disease such as cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003280544A1 true AU2003280544A1 (en) | 2004-05-25 |
Family
ID=4749533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003280544A Abandoned AU2003280544A1 (en) | 2002-10-29 | 2003-10-27 | A special kind of indole compounds, their preparation, and their use in treatment and prevention of those disease such as cancer |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN1199946C (en) |
AU (1) | AU2003280544A1 (en) |
WO (1) | WO2004039797A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101074229B (en) * | 2007-06-08 | 2010-09-01 | 无锡杰西医药科技有限公司 | 7-azaindirubin and 7-azaisoindigo derivative production and pharmaceutical use |
CN103333161B (en) * | 2013-05-28 | 2015-09-30 | 滁州市洛达生物科技有限公司 | The preparation of 1 '-oxo Indirubin and purposes |
CA3048357A1 (en) | 2016-12-29 | 2018-07-05 | Minoryx Therapeutics S.L. | Heteroaryl compounds and their use |
CN111808078B (en) * | 2020-06-22 | 2022-10-11 | 济南爱思医药科技有限公司 | Lenalidomide derivative for inhibiting IDO1 activity and preparation method and application thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS609023B2 (en) * | 1981-06-19 | 1985-03-07 | イスクラ産業株式会社 | Indirubin derivatives and antitumor agents containing them |
JPS617254A (en) * | 1984-06-20 | 1986-01-13 | Isukura Sangyo Kk | Bisindolinone and carcinostatic agent consisting essentially of same |
WO1999062503A2 (en) * | 1998-05-29 | 1999-12-09 | Cnrs (Centre National De Recherche Scientifique) France Innovation Scientifique Et Transfert | Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases |
HUP0200724A3 (en) * | 1999-04-12 | 2002-10-28 | Eisenbrand Gerhard | Indigoid bisindole derivatives and pharmaceurical compositions containing them |
FR2801216A1 (en) * | 1999-11-23 | 2001-05-25 | Centre Nat Rech Scient | Use of indirubine derivatives to inhibit 3 beta-glycogen synthase kinase, for the treatment of diabetes, neurodegenerative disorders, manic-depressive disorders, cancers, or parasites |
DE10061162A1 (en) * | 2000-11-30 | 2002-07-11 | Schering Ag | Aryl-substituted indirubin derivatives, their preparation and use |
-
2002
- 2002-10-29 CN CNB021385181A patent/CN1199946C/en not_active Expired - Fee Related
-
2003
- 2003-10-27 WO PCT/CN2003/000901 patent/WO2004039797A1/en not_active Application Discontinuation
- 2003-10-27 AU AU2003280544A patent/AU2003280544A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1424312A (en) | 2003-06-18 |
CN1199946C (en) | 2005-05-04 |
WO2004039797A1 (en) | 2004-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003290548A1 (en) | Prevention and treatment of synucleinopathic disease | |
AU2003243551A1 (en) | Use of an anti-endotoxin drug in the prevention and treatment of disease | |
AU2003239568A1 (en) | Pyrrolotriazinone compounds and their use to treat diseases | |
EP1587474A3 (en) | Fluoroalkoxy-substituted 1, 3-dihydro-isoindolyl compounds and their pharmaceutical uses | |
HK1076110A1 (en) | Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof | |
AUPS054702A0 (en) | Cancer therapy | |
HK1074446A1 (en) | 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof | |
HK1080447B (en) | Retinol derivatives, their use in the treatment of cancer and for potentiating the efficacy of other cytotoxic agents | |
AU2003212634A1 (en) | Compounds useful in the treatment of cancer | |
AU2003269018A1 (en) | Acylaminothiazole derivatives, preparation and therapeutic use thereof | |
AU2003236156A1 (en) | Pharmaceutical compositions used for immune disease treatment and improvement | |
HK1074444A1 (en) | Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof | |
AU2003238242A1 (en) | Use of an anti-endotoxin drug in the prevention and treatment of disease | |
AU2003298719A1 (en) | Treatment for sma disease | |
AU2003280544A1 (en) | A special kind of indole compounds, their preparation, and their use in treatment and prevention of those disease such as cancer | |
AU2002330724A1 (en) | Diagnosis, prevention and treatment of cancer | |
AU2003228339A1 (en) | Prevention and treatment of disease using angiogenesis-and/or tumor antigens | |
AU2003245858A1 (en) | Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases | |
AU2003255843A1 (en) | 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain | |
AU2002229870A1 (en) | Mikanolide derivatives, their preparation and therapeutic uses | |
AU2003900495A0 (en) | Aroylhydrazone derivatives and therapeutic uses thereof | |
AU2003219664A1 (en) | Methods and therapeutic compositions in the treatment of advanced cancer | |
AU2003264954A1 (en) | Pharmaceutical composition for prevention and treatment of kidney diseases | |
AU2003245674A1 (en) | Oral disease prevention and treatment | |
AU2003243215A1 (en) | Treatment for human papillomavirus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |